The Autism Biomarkers Consortium for Clinical Trials (ABC-CT) is seeking families to participate in a study to improve diagnosis and treatment in Autism Spectrum Disorder (ASD). 
We are currently recruiting both typically developing children and children with a diagnosis of ASD between the ages of 6 and 11 years old. Using EEG to measure brain function, eye tracking technology to measure visual attention, and automated recording techniques to assess behavior and speech, children will be monitored over a 6-month period. This community resource will also include DNA samples from children with ASD and their parents for use in future genetic studies. To learn more, please contact our research coordinator at (206) 221-7688 or abcct@uw.edu.